Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A <scp>SurvMark</scp>‐2 study
Citadel J. Cabasag, Melina Arnold, Mark J. Rutherford, Jacques Ferlay, Aude Bardot, Eileen Morgan, John Butler, Dianne L. O’Connell, Gregg Nelson, Claus Høgdall, Tine Henrichsen Schnack, Anna Gavin, Mark Elwood, Louise Hanna, Charlie Gourley, Prithwish De, Nathalie Saint‐Jacques, Lina Steinrud Mørch, Ryan Woods, Alon D. Altman, Peter Sykes, Paul A. Cohen, Orla McNally, Bjørn Møller, Patrick Paul Walsh, David Morrison, Freddie Bray, Isabelle Soerjomataram
Abstract
The aim of the study is to provide a comprehensive assessment of incidence and survival trends of epithelial ovarian cancer (EOC) by histological subtype across seven high income countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway and the United Kingdom). Data on invasive EOC diagnosed in women aged 15 to 99 years during 1995 to 2014 were obtained from 20 cancer registries. Age standardized incidence rates and average annual percentage change were calculated by subtype for all ages and age groups (15-64 and 65-99 years). Net survival (NS) was estimated by subtype, age group and 5-year period using Pohar-Perme estimator. Our findings showed marked increase in serous carcinoma incidence was observed between 1995 and 2014 among women aged 65 to 99 years with average annual increase ranging between 2.2% and 5.8%. We documented a marked decrease in the incidence of adenocarcinoma "not otherwise specified" with estimates ranging between 4.4% and 7.4% in women aged 15 to 64 years and between 2.0% and 3.7% among the older age group. Improved survival, combining all EOC subtypes, was observed for all ages combined over the 20-year study period in all countries with 5-year NS absolute percent change ranging between 5.0 in Canada and 12.6 in Denmark. Several factors such as changes in guidelines and advancement in diagnostic tools may potentially influence the observed shift in histological subtypes and temporal trends. Progress in clinical management and treatment over the past decades potentially plays a role in the observed improvements in EOC survival.